Keybank National Association Apellis Pharmaceuticals, Inc. Transaction History
Keybank National Association
- $24.1 Billion
- Q2 2024
A detailed history of Keybank National Association transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Keybank National Association holds 7,449 shares of APLS stock, worth $296,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,449
Previous 6,570
13.38%
Holding current value
$296,842
Previous $386,000
26.17%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
298Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$653 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$463 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$443 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$231 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.38B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...